The following five companies are seeking investment via the Network as a result of the 15 February 2012 OION investment meeting at the Said Business School in Oxford. The descriptions available summarise the investment proposal made by the company. The information is provided by the company and has not been vetted in any way by OION.
If you are interested in receiving further information on any of the companies then please contact us.
|Company A: £500k|
2%-4% of children have strabismus (squint) – a
chief cause of amblyopia (“lazy eye”). Amblyopia is responsible for
visual loss in one eye in children and young adults - 10 times more
than all other causes combined. Effectiveness of treatment reduces
over time and after the age of 7 or 8, loss of vision can be permanent.
Importantly, a large proportion of squints are not noticeable to the
unskilled eye. Primary care practitioners - GPs, paediatricians, nurses
and health visitors - use manual tests to detect squints, as these
are the only tests available to them, but they are difficult to administer
reliably and accurately to the under 5’s. Even trained optometrists
find this age group a challenge to examine reliably.
|Company B: £650k|
Company B is a mobile service which is redefining the way we travel abroad connected. Our travel solutions allow travelers to remain connected globally, while avoiding exorbitant roaming charges. Connectivity is an everyday essential, yet remains a challenge when abroad - tep solves this problem, while also enhancing the travel experience with a mobile app which serves as a one-stop shop for local offers and information.
We are in the process of meeting investors to discuss the next stage of our business plan; launching a global product (with our own branded SIM), developing our travel app, assembling a board of directors and franchising our service to retail outlets in airports (Excess Baggage Company, Airport Concierge) and car rental companies (Europcar, AVIS, Enterprise).
Our travel connectivity solutions have been tested and validated by the market, reaching positive EBITDA, achieving prominent media coverage (NYT, BBC), and establishing strategic relationships (Visit Britain, Expedia) in just 12 months.
Our niche focus means we can concentrate on providing a simple and world-class service which is built for travelers. Through our connectivity and app solutions, we can lay claim to the most integrated and complete travel solution.
Company B is raising up to £650,000 through the issuance of new equity shares.
|Company C: £150k|
Company C develops and commercialises nanofibre scaffolds that support the growth of cells in 3D. Uniquely in Europe, Company C designs and manufactures high quality products from biocompatible polymers for use in regenerative medicine, stem cell therapeutics and drug discovery.
An STFC spin-out, Company C has access to world-class facilities at the Rutherford Appleton Laboratory at low cost, and possesses expert know-how to produce highly consistent, easy-to-use products. Since foundation (2010) Company C has launched a range of tissue engineering laboratory consumables, sold to big pharma, filed its first patent and established industrial collaborations to co-develop medical devices. Company C is developing microplates with in-built scaffolds for oncology drug discovery where more predictive in vitro 3D cell-based assays could reduce the rate of expensive clinical failures (95%) and replace certain animal studies.
Company C has raised £250K and now seeks £150K to fund operations until income supports investment (mid 2013). 2012 income is forecast at £146K with a gross margin of 70%. The company will exit by trade sale to a regenerative medicine pharma company in 3-5 years.
The team has polymer chemistry, electrospinning and stem cell expertise
as well as experienced management.
|Company D: £315k|
Company D is a UK start-up with a fully-functional advanced LED driver technology and product family, addressing the outstanding driver requirements of the commercial and industrial LED lighting markets.
Over the next four years, the predicted production value CAGR for
LED drivers aimed specifically at the lighting market is 40%. This
growth will be shared by suppliers that can meet stringent requirements,
Company D has developed a novel LED driver product family (patent pending) that addresses all three of these requirements. Having completed its main development programme in November 2011, Company D has already received interest from two US-based LED lighting companies. The next steps are to achieve first sales in 2012 and to convert these into repeatable orders.
Company D’s founders have between them, long-standing experience in the areas of electronics design, business development, IP licensing, product development and marketing. Having ‘bootstrapped’ the company, they now seek investment, to be directed toward sales, marketing, product qualification and IP protection activities over the next two years, with the aim of achieving a growing revenue stream of £6.3M pa by the end of 2016, when the founders plan to exit, via trade-sale or IPO.
|Company E: £2m|
Company E have developed a unique software solution
suite that integrates seamlessly with a business’s IT systems; the
software not only allows remote management and problem solving for
the device and its user, but also gathers analytics on the specific
use of the device as it relates to the businesses processes enabling
informed process optimisation.
View details on the Next Meeting.
View Diary of all Investment Meetings.
View our success stories - brief case studies of companies that have successfully raised funds through OION.